Company intelligence / Profile preview

Modern AlkaMe

Irvine, California, United States

Ownership: Private
Development stage: Other

Overview

Modern AlkaMe (later rebranded as Biomarker Labs) was a digital health and biohacking company that developed a personalized health platform to measure and optimize the effects of dietary supplements and nootropics. Founded in 2014 and incubated at EvoNexus, the company built a machine-learning digital phenotype platform that aggregated user health data from electronic health records, blood panels, genotypes, and over 400 wearable devices. The platform provided personalized, data-driven recommendations for consumers seeking safe and sustainable cognitive enhancement tailored to their unique biochemistry. The company raised over $2 million and went through the 500 Startups accelerator before winding down operations in 2021.

Industry: Food & Nutrition

Beyond the preview

Go deeper on Modern AlkaMe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Modern AlkaMe.

Explore the full profile